These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 17671198)

  • 1. Targeting matrix metalloproteinases and endothelial cells with a fusion peptide against tumor.
    Zou Y; Chen Y; Jiang Y; Gao J; Gu J
    Cancer Res; 2007 Aug; 67(15):7295-300. PubMed ID: 17671198
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapeutic targeting of angiogenesis with a recombinant CTT peptide-endostatin mimic-kringle 5 protein.
    Wang H; Yang Z; Gu J
    Mol Cancer Ther; 2014 Nov; 13(11):2674-87. PubMed ID: 25127900
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mutation of human plasminogen kringle 1-5 enhances anti-angiogenic action via increased interaction with integrin alpha(v)beta(3).
    Chang PC; Chang YJ; Wu HL; Chang CW; Lin CI; Wang WC; Shi GY
    Thromb Haemost; 2008 Apr; 99(4):729-38. PubMed ID: 18392331
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of cloned tumstatin-related and angiogenesis-inhibitory peptides on proliferation and apoptosis of endothelial cells.
    Zhang GM; Zhang YM; Fu SB; Liu XH; Fu X; Yu Y; Zhang ZY
    Chin Med J (Engl); 2008 Nov; 121(22):2324-30. PubMed ID: 19080341
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasminogen derivatives encoding kringles 1-4 and kringles 1-5 exert indirect antiangiogenic and direct antitumoral effects in experimental lung cancer.
    Schmitz V; Raskopf E; Gonzalez-Carmona MA; Vogt A; Kornek M; Sauerbruch T; Caselmann WH
    Cancer Invest; 2008 Jun; 26(5):464-70. PubMed ID: 18568768
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization and biological activities of recombinant human plasminogen kringle 1-3 produced in Escherichia coli.
    You WK; So SH; Sohn YD; Lee H; Park DH; Chung SI; Chung KH
    Protein Expr Purif; 2004 Jul; 36(1):1-10. PubMed ID: 15177278
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antitumor and antimetastatic activities of 4-hydroxyderricin isolated from Angelica keiskei roots.
    Kimura Y; Taniguchi M; Baba K
    Planta Med; 2004 Mar; 70(3):211-9. PubMed ID: 15114497
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vaccination with viable human umbilical vein endothelial cells prevents metastatic tumors by attack on tumor vasculature with both cellular and humoral immunity.
    Chen XY; Zhang W; Zhang W; Wu S; Bi F; Su YJ; Tan XY; Liu JN; Zhang J
    Clin Cancer Res; 2006 Oct; 12(19):5834-40. PubMed ID: 17020991
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Kringle 5 causes cell cycle arrest and apoptosis of endothelial cells.
    Lu H; Dhanabal M; Volk R; Waterman MJ; Ramchandran R; Knebelmann B; Segal M; Sukhatme VP
    Biochem Biophys Res Commun; 1999 May; 258(3):668-73. PubMed ID: 10329443
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antibody-directed targeting of angiostatin's receptor annexin II inhibits Lewis Lung Carcinoma tumor growth via blocking of plasminogen activation: possible biochemical mechanism of angiostatin's action.
    Sharma MR; Rothman V; Tuszynski GP; Sharma MC
    Exp Mol Pathol; 2006 Oct; 81(2):136-45. PubMed ID: 16643891
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro and in vivo antiangiogenic activity of a novel deca-peptide derived from human tissue-type plasminogen activator kringle 2.
    Su L; Xu X; Zhao H; Gu Q; Zou H
    Biochem Biophys Res Commun; 2010 Jun; 396(4):1012-7. PubMed ID: 20471363
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Beta-carotene inhibits tumor-specific angiogenesis by altering the cytokine profile and inhibits the nuclear translocation of transcription factors in B16F-10 melanoma cells.
    Guruvayoorappan C; Kuttan G
    Integr Cancer Ther; 2007 Sep; 6(3):258-70. PubMed ID: 17761639
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Suppression of lung tumor growth and metastasis in mice by adeno-associated virus-mediated expression of vasostatin.
    Cai KX; Tse LY; Leung C; Tam PK; Xu R; Sham MH
    Clin Cancer Res; 2008 Feb; 14(3):939-49. PubMed ID: 18245558
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anticancer treatment of endostatin gene therapy by targeting tumor neovasculature in C57/BL mice.
    Jia S; Zhu F; Li H; He F; Xiu R
    Clin Hemorheol Microcirc; 2000; 23(2-4):251-7. PubMed ID: 11321448
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Angiostatin potentiates cyclophosphamide treatment of metastatic disease.
    Mauceri HJ; Seetharam S; Beckett MA; Schumm LP; Koons A; Gupta VK; Park JO; Manan A; Lee JY; Montag AG; Kufe DW; Weichselbaum RR
    Cancer Chemother Pharmacol; 2002 Nov; 50(5):412-8. PubMed ID: 12439600
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Decursin and decursinol angelate inhibit VEGF-induced angiogenesis via suppression of the VEGFR-2-signaling pathway.
    Jung MH; Lee SH; Ahn EM; Lee YM
    Carcinogenesis; 2009 Apr; 30(4):655-61. PubMed ID: 19228635
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PNAS-4, a novel pro-apoptotic gene, can potentiate antineoplastic effects of cisplatin.
    Yuan Z; Yan F; Wang YS; Liu HY; Gou LT; Zhao XY; Lai ST; Deng HX; Li J; Ding ZY; Xiong SQ; Kan B; Mao YQ; Chen LJ; Wei YQ; Zhao X
    Cancer Chemother Pharmacol; 2009 Dec; 65(1):13-25. PubMed ID: 19387645
    [TBL] [Abstract][Full Text] [Related]  

  • 18. mTOR inhibitor RAD001 (everolimus) has antiangiogenic/vascular properties distinct from a VEGFR tyrosine kinase inhibitor.
    Lane HA; Wood JM; McSheehy PM; Allegrini PR; Boulay A; Brueggen J; Littlewood-Evans A; Maira SM; Martiny-Baron G; Schnell CR; Sini P; O'Reilly T
    Clin Cancer Res; 2009 Mar; 15(5):1612-22. PubMed ID: 19223496
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Specific occlusion of murine and human tumor vasculature by VCAM-1-targeted recombinant fusion proteins.
    Dienst A; Grunow A; Unruh M; Rabausch B; Nör JE; Fries JW; Gottstein C
    J Natl Cancer Inst; 2005 May; 97(10):733-47. PubMed ID: 15900043
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Secreted human apolipoprotein(a) kringle IV-10 and kringle V inhibit angiogenesis and xenografted tumor growth.
    Shen L; Zhu X; Wang Y; Zeng W; Wu G; Xue H; Chen B
    Biol Chem; 2008 Feb; 389(2):135-41. PubMed ID: 18163888
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.